Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Patel

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Plos One|November 16, 2016
Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder CancersDoris Kim, YounJeong Choi, James Ireland, et al.
Healthcare (Amsterdam, Netherlands)|October 31, 2020
Digital triage: Novel strategies for population health management in response to the COVID-19 pandemicLucinda Lai, Kelley A Wittbold, Farah Z Dadabhoy, et al.
Plos One|June 3, 2022
Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance studySarah Naz-McLean, Andy Kim, Andrew Zimmer, et al.
Scientific Reports|May 21, 2026
Patient-friendly simplification and translation of neuroradiology impressions using artificial intelligenceWendy Sun, Advait Patil, Maria A Vicent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefitHartmut Koeppen, Wei Yu, Jiping Zha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2021
Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC: Initial Results of the Phase 2 ALK-Positive CohortRafal Dziadziuszko, Tony Mok, Solange Peters, et al.
Plos One|July 19, 2012
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosisRohit Vashisht, Anupam Kumar Mondal, Akanksha Jain, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Plos One|November 16, 2016
Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder CancersDoris Kim, YounJeong Choi, James Ireland, et al.
Healthcare (Amsterdam, Netherlands)|October 31, 2020
Digital triage: Novel strategies for population health management in response to the COVID-19 pandemicLucinda Lai, Kelley A Wittbold, Farah Z Dadabhoy, et al.
Plos One|June 3, 2022
Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance studySarah Naz-McLean, Andy Kim, Andrew Zimmer, et al.
Scientific Reports|May 21, 2026
Patient-friendly simplification and translation of neuroradiology impressions using artificial intelligenceWendy Sun, Advait Patil, Maria A Vicent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefitHartmut Koeppen, Wei Yu, Jiping Zha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2021
Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC: Initial Results of the Phase 2 ALK-Positive CohortRafal Dziadziuszko, Tony Mok, Solange Peters, et al.
Plos One|July 19, 2012
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosisRohit Vashisht, Anupam Kumar Mondal, Akanksha Jain, et al.
Pageof 15